永久性心脏起搏器植入术后起搏阈值升高患者的临床特点及其相关影响因素分析  

Clinical Features and Related Influence Factors of Patients with Elevated Pacing Thresholds After Permanent Pacemaker Implantation Surgery

作　　者：李日健[1] 黄瑞娜[1] 吴铿[1] 游琼[1] 叶少强[1] 李上海[1] 闫海[1] 郑锡锋 

机构地区：[1]广东医学院附属医院心血管内科,广东湛江524001

出　　处：《临床医学工程》2016年第2期187-188,共2页Clinical Medicine & Engineering

摘　　要：目的研究永久性心脏起搏器植入术后起搏阈值升高患者的临床特点。方法回顾性分析826例植入永久性心脏起搏器患者的临床资料,根据有无起搏器阈值升高分为起搏器阈值升高组﹙A组,92例﹚及起搏器阈值正常组﹙B组,734例﹚。比较两组的临床特点,分析起搏器阈值升高相关的危险因素。结果与起搏阈值正常组比较,起搏阈值升高组冠心病、充血性心衰、糖代谢异常、高脂血症等因素发生率明显增加,且起搏阈值升高与上述因素具有相关性。结论冠心病、糖代谢异常、充血性心衰、高脂血症等常见病的永久性心脏起搏器植入患者,其起搏器阈值升高的发病率明显增加,考虑可能与心肌纤维化有关。Objective To study the clinical features of patients with elevated pacing threshold after permanent pacemaker implantation surgery. Methods Clinical data of 826 patients with permanent pacemaker implantation surgery were retrospectively analyzed.All patients were divided into elevated pacing threshold group（group A, 92 cases） and normal pacing threshold group（group B, 734 cases）.The clinical features of two groups were compared, the related risk factors of elevated pacing threshold was analyzed. Results Compared with normal pacemaker threshold group, the incidence of CHD, CHF, abnormal glucose metabolism, HLP of elevated pacemaker threshold group increased significantly. The above factors were related with elevated pacing thresholds. Conclusions The incidence of elevated pacemaker threshold in patients with permanent pacemaker implantation surgery complicating CHD, CHF, abnormal glucose metabolism,HLP increased significantly, which may be related with myocardial fibrosis.

关 键 词：心脏起搏器 起搏阈值 冠心病 心力衰竭 糖代谢异常 高脂血症 

分 类 号：R541.7[医药卫生—心血管疾病]